Regeneron Says Trump Test Results May Show Drug’s Antibodies

(Bloomberg) -- Regeneron Pharmaceuticals Inc. said that the presence of antibodies in President Donald Trump’s blood could be the result of him taking the company’s experimental Covid-19 treatment ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.